BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12083749)

  • 1. Modulation by 5-hT2A receptors of aggressive behavior in isolated mice.
    Sakaue M; Ago Y; Sowa C; Sakamoto Y; Nishihara B; Koyama Y; Baba A; Matsuda T
    Jpn J Pharmacol; 2002 May; 89(1):89-92. PubMed ID: 12083749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of benzodiazepine binding sites in an antiaggressive effect by 5-HT(1A) receptor activation in isolated mice.
    Sakaue M; Ago Y; Murakami C; Sowa C; Sakamoto Y; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2001 Dec; 432(2-3):163-6. PubMed ID: 11740952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze.
    Sakaue M; Ago Y; Sowa C; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2003 Jan; 458(1-2):141-4. PubMed ID: 12498918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice.
    Abe M; Nakai H; Tabata R; Saito K; Egawa M
    Jpn J Pharmacol; 1998 Mar; 76(3):297-304. PubMed ID: 9593223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice.
    Sakaue M; Ago Y; Baba A; Matsuda T
    Psychopharmacology (Berl); 2003 Oct; 170(1):73-9. PubMed ID: 12768276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
    Sugimoto Y; Yamada J
    Biol Pharm Bull; 2000 Dec; 23(12):1521-3. PubMed ID: 11145190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.
    Koskinen T; Ruotsalainen S; Puumala T; Lappalainen R; Koivisto E; Männistö PT; Sirviö J
    Neuropharmacology; 2000 Jan; 39(3):471-81. PubMed ID: 10698013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice.
    Ago Y; Sakaue M; Baba A; Matsuda T
    J Neurochem; 2002 Oct; 83(2):353-9. PubMed ID: 12423245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice.
    Takahashi S; Yoshinobu Y; Aida R; Shimomura H; Akiyama M; Moriya T; Shibata S
    J Neurosci Res; 2002 May; 68(4):470-8. PubMed ID: 11992474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that 5-HT2A receptors are not involved in 5-HT-mediated thermoregulation in mice.
    Morishima Y; Shibano T
    Pharmacol Biochem Behav; 1995 Dec; 52(4):755-8. PubMed ID: 8587916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)amino]propoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.
    Matsuda T; Yoshikawa T; Suzuki M; Asano S; Somboonthum P; Takuma K; Nakano Y; Morita T; Nakasu Y; Kim HS
    Jpn J Pharmacol; 1995 Dec; 69(4):357-66. PubMed ID: 8786639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional alteration of brain dopaminergic system in isolated aggressive mice.
    Matsuda T; Sakaue M; Ago Y; Sakamoto Y; Koyama Y; Baba A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Sep; 21(3):71-6. PubMed ID: 11769459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
    Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.